Cerenome is trading 5% up at $3.11, with the move appearing consistent with broader risk-on sentiment.

  • No new company-specific announcement dated August 25, 2026 was identified.
  • Recent coverage centers on August 14 quarterly results and an August 20 conference-presentation update.
  • The Nasdaq is up 0.59% and the S&P 500 is up 0.31%; investors await Jackson Hole developments.